Testosterone levels and coronary lesion complexity in young men
Official title: Impact of Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males
Run by Sohag University · NCT07076771 · Data updated 2026-11-12
We will test whether blood testosterone levels are linked to how complex coronary artery blockages are in men under 45 with premature ischemic heart disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 45 Years |
| Sex | Men only |
| Enrollment | 50 (estimated) |
| Sponsor | Sohag University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | August 1, 2025 |
| Study ends | August 1, 2025 |
| Registry record updated | July 22, 2025 |
| Trial ID | NCT07076771 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Men younger than 45 diagnosed with premature ischemic heart disease who are undergoing elective coronary angiography and have not used testosterone therapy or anabolic steroids.
✕Probably not a fit
Patients with a recent acute coronary syndrome, prior hypogonadism or testosterone/anabolic steroid use, active cancer, significant liver or kidney disease, or on medications that affect sex hormones are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls men under 45 with premature ischemic heart disease who are scheduled for elective coronary angiography. Investigators will measure serum testosterone and determine lesion complexity using the SYNTAX score from the angiograms. The analysis will look for associations between testosterone level and angiographic complexity while adjusting for traditional cardiovascular risk factors. Results aim to clarify whether hormonal status relates to the severity and complexity of early-onset coronary artery disease.
Why it matters
Potential benefit: If a link is confirmed, measuring testosterone could help identify young men at higher risk of complex coronary disease and inform early risk-reduction strategies.
How similar studies have gone: Prior observational work has linked low testosterone to worse metabolic and cardiovascular risk profiles, but direct evidence tying testosterone to angiographic lesion complexity is limited, so this is largely exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male patients aged \<45 years. * Diagnosed with premature ischemic heart disease. * Undergoing elective coronary angiography for suspected coronary artery disease (CAD) . Exclusion Criteria: * History of acute coronary syndrome within the preceding 3 months. * Prior diagnosis of hypogonadism or history of testosterone replacement therapy or anabolic steroid use. * Active neoplasm or history of chemotherapy. * Known hepatic cirrhosis, chronic kidney disease, or end-stage renal disease. * Use of medications known to affect sex hormone levels (e.g., spironolactone, ketoconazole). * Endocrine disorders such as sickle cell anemia or celiac disease.
Where it's running
-
Sohag University
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Remon S Adly, MD
- Email: remonsaleh@yahoo.com
- Phone: 00201221878986
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Statin effects on hormones and erectile function in middle-aged men
This will test whether different doses of pitavastatin or rosuvastatin change sex hormone levels and improve erectile function in sexually active men aged 40-65 with high cardiovascular risk.
-
Beetroot juice to boost blood vessels, insulin sensitivity, and exercise in prediabetes on vs. off metformin
In people with prediabetes, this study tests whether short-term inorganic nitrate from beetroot juice can improve blood vessel health, insulin sensitivity, and exercise capacity, and compares those already taking metformin with those who are not.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.